LINC00709

Across TCGA pan-cancer cohorts, LINC00709 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC00709 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC00709 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC00709 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

BLCA, COAD, and UCEC are the cancer types where LINC00709 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Quartile	All	0.748	0.569	<.001	78	view →
COAD	OS	Tertile	III,IV	0.154	0.786	<.001	72	view →
UCEC	DFS	Tertile	All	0.292	0.682	.002	72	view →
HNSC	DFS	Tertile	II,III,IV	0.204	0.697	.003	54	view →
ESCA	OS	Tertile	All	0.400	0.719	.002	51	view →
STAD	DFS	Tertile	All	0.443	0.734	.008	42	view →
LGG	OS	Tertile	All	0.375	0.815	<.001	42	view →
KIRC	DFS	Tertile	IV	0.114	0.626	<.001	36	view →
LUSC	OS	Tertile	All	0.352	0.728	.023	18	view →
SKCM	DFS	Tertile	All	0.434	0.759	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

LINC00709–BLCA (OS)

Open the BLCA breakdown →